Back to search
Recurrent or Progressive High Grade Meningioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent or Progressive High Grade Meningioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent or Progressive High Grade Meningioma trials you may qualify forThis study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS)…
This multi-site, Phase 2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (peri…
This is a randomized, controlled, open-label, multicenter, Phase II clinical study designed to evaluate the efficacy and safety of SYHA1813 compared to investig…
This phase I trial studies the side effects and best dose of palbociclib isethionate in treating younger patients with central nervous system tumors that have g…